Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) and Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Insider & Institutional Ownership 5.7% of Ampio […]

ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) and Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Valuation and Earnings This table compares ARS […]

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) and Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations. Valuation and Earnings This table compares Lexicon […]